
Sign up to save your podcasts
Or


Profound autism prevalence rose from 2002 to 2016, though not nearly as much as non-profound autism did.
Researchers and clinicians were quick to point out the flaws in the study, and a flood of work refuted it.
In this edition of Null and Noteworthy, researchers upend early interventions and diagnostic boundaries.
The Gender Self-Report could help autism researchers include more gender-diverse people across a range of ages and neurotypes in their work.
A study published last week in JAMA Pediatrics suggests that autism is more common among people born in areas with high levels of lithium in drinking water, but it is too soon to say whether prenatal lithium exposure is truly a concern.
The mutation prevents certain amino acids from entering neurons, causing the cells to die early in development.
The result raises hopes for an ongoing clinical trial in people — and offers fresh insight into the biology of imprinting and the UBE3A antisense transcript.
The changes may help explain the link between maternal infection and autism, though more research is needed.
By revealing differences between autistic and non-autistic children, it could help identify autism in babies.
This month’s issue of the Going on Trial newsletter examines personalized therapies for rare conditions, Acadia’s new drug for Rett syndrome and developments in a cord-blood program, among other autism-related drug trial news.
From the publisher's feed

43,801 Listeners

7,608 Listeners

8,747 Listeners

1,982 Listeners

542 Listeners

420 Listeners

172 Listeners

10 Listeners

111,868 Listeners

56,446 Listeners

6,584 Listeners

5,554 Listeners

29,187 Listeners

15,915 Listeners

1,651 Listeners

9 Listeners

750 Listeners